Prohibition or profit motive: competing visions for the endgameClive Bates
This document discusses competing visions for reducing tobacco-related harm and cigarette consumption globally by 2040. It summarizes the view that prohibition of cigarettes is unlikely to succeed and may backfire, while introducing reduced-risk nicotine products could displace smoking if regulated appropriately. Charts show global cigarette consumption trends and hypothetical scenarios where safer nicotine products capture market share from cigarettes. The argument is made for an approach that balances public health, individual rights, and business interests to maximize harm reduction opportunities.
Regulation: why less is more... E-cigarette Summit 12 November 2013 - Clive B...Clive Bates
My presentation covering why 'less is more' when it comes to regulating low risk alternatives to cigarettes such as e-cigarettes. Too much regulation will limit appeal, increase costs, raise barriers to entry and inhibit innovation. I also urge a focus on the huge potential benefits of low-risk alternatives to smoking instead of obsession over minor or implausible risks.
This document summarizes information presented at a tobacco harm reduction conference on the public health benefits of tobacco harm reduction. It discusses estimates of the relative harm of nicotine products, value propositions for smokers to switch to lower-risk alternatives like e-cigarettes, real-world examples of smokers switching successfully to e-cigarettes, and projections of global cigarette consumption trends with and without the introduction of reduced-risk nicotine products. It also examines how moral panics have emerged around issues like e-cigarette poisoning, use by youth, hidden toxicants, and youth-oriented flavors.
Vaping and tobacco: six things you need to know about harm reductionClive Bates
1. Smoking has not gone away
2. Technologies to obsolete cigarettes
3. Risks and risk (mis)perceptions
4. The public health mechanism and the pleasure principle
5. The youth vaping epidemic – a harder look
6. Policymaking and perverse consequences
Innovation for Consumers: E-cigarettes and novel tobacco products - Part of t...Clive Bates
This document discusses e-cigarettes and novel tobacco products. It argues that they are substantially less harmful than combustible cigarettes and have the potential to significantly reduce smoking rates and associated deaths. However, regulations should balance this potential benefit with preventing unintended consequences like perpetuating smoking or increasing youth uptake. The document proposes risk-proportionate regulations and taxes to incentivize switching from cigarettes, along with standards, marketing restrictions, and age limits, while ensuring products remain appealing to smokers trying to quit. The goal is harm reduction for populations according to the WHO framework convention on tobacco control.
Bad science - 10 insights for advocatesClive Bates
1. Science and evidence is often overrated, and intuitions come before strategic reasoning.
2. Arguments should be proportional to the issue; don't bring a knife to a gun fight.
3. Authority from experts can be leveraged; a quote from the Royal College of Physicians said e-cigarette risks are unlikely to exceed 5% of smoking risks, and may be lower.
Prohibition or profit motive: competing visions for the endgameClive Bates
This document discusses competing visions for reducing tobacco-related harm and cigarette consumption globally by 2040. It summarizes the view that prohibition of cigarettes is unlikely to succeed and may backfire, while introducing reduced-risk nicotine products could displace smoking if regulated appropriately. Charts show global cigarette consumption trends and hypothetical scenarios where safer nicotine products capture market share from cigarettes. The argument is made for an approach that balances public health, individual rights, and business interests to maximize harm reduction opportunities.
Regulation: why less is more... E-cigarette Summit 12 November 2013 - Clive B...Clive Bates
My presentation covering why 'less is more' when it comes to regulating low risk alternatives to cigarettes such as e-cigarettes. Too much regulation will limit appeal, increase costs, raise barriers to entry and inhibit innovation. I also urge a focus on the huge potential benefits of low-risk alternatives to smoking instead of obsession over minor or implausible risks.
This document summarizes information presented at a tobacco harm reduction conference on the public health benefits of tobacco harm reduction. It discusses estimates of the relative harm of nicotine products, value propositions for smokers to switch to lower-risk alternatives like e-cigarettes, real-world examples of smokers switching successfully to e-cigarettes, and projections of global cigarette consumption trends with and without the introduction of reduced-risk nicotine products. It also examines how moral panics have emerged around issues like e-cigarette poisoning, use by youth, hidden toxicants, and youth-oriented flavors.
Vaping and tobacco: six things you need to know about harm reductionClive Bates
1. Smoking has not gone away
2. Technologies to obsolete cigarettes
3. Risks and risk (mis)perceptions
4. The public health mechanism and the pleasure principle
5. The youth vaping epidemic – a harder look
6. Policymaking and perverse consequences
Innovation for Consumers: E-cigarettes and novel tobacco products - Part of t...Clive Bates
This document discusses e-cigarettes and novel tobacco products. It argues that they are substantially less harmful than combustible cigarettes and have the potential to significantly reduce smoking rates and associated deaths. However, regulations should balance this potential benefit with preventing unintended consequences like perpetuating smoking or increasing youth uptake. The document proposes risk-proportionate regulations and taxes to incentivize switching from cigarettes, along with standards, marketing restrictions, and age limits, while ensuring products remain appealing to smokers trying to quit. The goal is harm reduction for populations according to the WHO framework convention on tobacco control.
Bad science - 10 insights for advocatesClive Bates
1. Science and evidence is often overrated, and intuitions come before strategic reasoning.
2. Arguments should be proportional to the issue; don't bring a knife to a gun fight.
3. Authority from experts can be leveraged; a quote from the Royal College of Physicians said e-cigarette risks are unlikely to exceed 5% of smoking risks, and may be lower.
Tobacco Harm Reduction - an introductionClive Bates
This document provides an introduction to tobacco harm reduction and alternative nicotine products such as e-cigarettes. It summarizes statements from public health organizations that find e-cigarettes to be much less harmful than combustible cigarettes. Research shows e-cigarettes help smokers quit at the population level and are effective cessation tools. The document argues for risk-proportionate regulation and taxation of nicotine products to incentivize smokers to switch to less harmful options and further reduce smoking rates.
E-cigarette Summit US presentation 2018Clive Bates
My presentation at the E-cigarette Summit Washington DC, 30 April 2018. "The urge to ban: 10 questions to ask first" calling for calm over flavors and the latest moral panic over JUUL.
This document outlines six insights on harm reduction:
1. Policies should focus on actual harm rather than products themselves. Harm from smoking, alcohol, drugs, gambling, etc. should be the focus.
2. Policies themselves can cause unintended harm, such as bans on e-cigarettes increasing smoking rates in some cases. The potential harms of policies must be considered.
3. Context is important when considering harm reduction policies. What works in one situation may not be effective in another due to differing contexts.
4. Policies should consider who is actually at risk rather than entire populations. For issues like obesity and salt, not all groups face the same degree of risk.
5. Appro
Is nicotine reduction a viable policy for tobacco control? No, Definitely not...Clive Bates
My critique of the proposal that regulators should reduce the concentration of nicotine in cigarettes to a sub-addictive level - effectively a prohibition of cigarettes as we know them.
Presentation at SRNT 2017 in Florence, Italy on 8 March 2017.
The MRTP process - Seven provocations - FDLI webinar 30 July 2020Clive Bates
My presentation for a Food and Drug Law Institute webinar on the FDA's Modified Risk Tobacco Product process for making risk-related claims about tobacco and nicotine products
NYU College of Global Health - E-cigarette seminar - New YorkClive Bates
E-Cigarettes: The Tectonic Shift in Nicotine and Tobacco Consumption: Opportunity or Threat to Saving Lives?
Clive Bates
Friday, October 19, 2018
NYU School of Law, Greenberg Lounge
40 Washington Square South, New York, New York
Tobacco harm reduction - meetings with Hill staff Clive Bates
This document discusses efforts to reduce smoking and associated harms. It notes that while 36.5 million Americans smoke, consuming 264 billion cigarettes in 2015, smoking causes over 480,000 deaths per year at a cost of over $300 billion. New reduced-risk nicotine products like e-cigarettes and heated tobacco have potential to significantly reduce smoking's toll if made accessible through sensible regulation rather than restrictive policies that protect the cigarette trade. The Royal College of Physicians reviewed evidence that e-cigarettes are much less harmful than smoking and effective for smoking cessation. Most youth e-cigarette use involves just flavors without nicotine. Banning flavors could undermine harm reduction efforts. The proposed Cole-Bishop bill offers a responsible
E-cigarette Summit - The New Tobacco Wars - 7 December 2021Clive Bates
The presentation gives my take on the conflict raging in tobacco control. It looks at where things are going wrong in science, risk communication, policy, and youth politics. It then looks at causes: institutional and cultural inertia. And finally, finds hope in the basic processes of innovation.
Respect Vapers Ireland - webinar on tobacco harm reductionClive Bates
This document summarizes six key things to know about tobacco harm reduction:
1. Smoking prevalence remains high despite efforts. New reduced risk nicotine products like e-cigarettes can help obsolete cigarettes.
2. Expert reviews find e-cigarettes are much less harmful than smoking and can help smokers quit. However, risk perceptions are often exaggerated.
3. The public health benefit comes from addicted smokers switching to less harmful options, not from promoting e-cigarette use alone.
4. Policies should balance appropriate youth protections with supporting harm reduction for adults. Overly restrictive policies can backfire by perpetuating smoking.
1. The document discusses the potential for e-cigarettes and other reduced risk nicotine products to significantly reduce smoking-related harm and death on a global scale. It outlines scenarios where low-risk nicotine products could drive down the number of smokers from over 1 billion currently to just 5% of the global adult population by 2050.
2. However, it notes that an over-regulated environment that reduces product appeal and diversity could limit the public health benefits by decreasing the number of smokers who switch to less harmful alternatives. The document argues for a balanced, evidence-based approach that recognizes both the massive potential gains and relatively minor risks of low-risk nicotine products.
3. In conclusion, it advocates that
Competent or careless? Directions in European policy on low-risk nicotine pr...Clive Bates
Presentation to ENDS conference, 20 April 2021.
Discussion of (1) the threat posed by upcoming EU regulatory developments on tobacco/nicotine; (2) the importance of understanding the underlying public health model; (3) the danger of perverse unintended consequences; (4) the adolescent vaping narrative and what is wrong with it; (5) the proactive alternative - risk-proportionate regulation.
Nicotina - Reducción de riesgos y daños / Nicotine - Risk and Harm ReductionClive Bates
Presentación en línea para el seminario de políticas en Colombia enfocado en políticas de vapeo y consecuencias no deseadas /
Presentation online for policy seminar in Colombia focussed on vaping policy and unintended consequences
Tobacco harm reduction in the UK: e-cigarettes (EC) are making a differenceClive Bates
The document discusses the success of e-cigarettes in helping smokers quit in Leicester City, UK. It notes that success rates were up to 20% higher using e-cigarettes compared to nicotine replacement therapy alone. A stop smoking service in Leicester City began offering free e-cigarette starter kits in 2014 and has seen consistently high quit rates each year since. Common myths about potential health harms, nicotine addiction, e-cigarettes not reflecting smoker preferences, gateway effects, and lack of evidence are addressed. Key organizations in the UK support e-cigarettes as much safer than smoking and effective for harm reduction.
Seven insights into tobacco harm reductionClive Bates
1st Tobacco Harm Reduction Malaysia Scientific Meeting
21 November 2021.
1. The problem is smoking
2. Smoke-free alternatives
3. Quitting smoking with smoke-free alternatives
4. Health concerns
5. Youth vaping
6. Policy and unintended consequences
7. Innovation (and its enemies)
This document discusses various issues related to the regulation of e-cigarettes and vaping. It notes that over-regulation can diminish returns and impose unnecessary costs and restrictions. Too much regulation could compromise product design and appeal, and allow larger tobacco companies to dominate at the expense of smaller manufacturers. There is concern that changing public perceptions of e-cigarettes, driven by misinformation about potential health risks that are not supported by science, could undermine their ability to help smokers quit and reduce harm. The document advocates an evidence-based approach to regulation and public messaging, highlighting that e-cigarettes are much less harmful than smoking and show promise as a smoking cessation tool.
FDLI - Lesson for the US from other jurisdictions - the United Kingdom -29 Oc...Clive Bates
Presentation on the most significant differences between US and UK/EU regulation of tobacco and vaping products. FDLI Tobacco and Nicotine Products Regulation and Policy Conference
This document discusses efforts to develop safer cigarettes through modifying tobacco and reducing tar and toxic compounds. In the 20th century, tobacco companies experimented with adding filters and other additives to cigarettes in attempts to make them less hazardous. One promising attempt involved adding palladium to tobacco, but this "Epic" brand was withheld from the market due to pressure from tobacco control groups and other companies. Later attempts in the 1970s by government and industry to develop "tobacco substitutes" and ultra-low tar cigarettes also failed commercially. Opponents argued safer cigarettes could deter quitting and mask the true risks of smoking. Overall, fully neutralizing the harms of smoking has proved very difficult due to the many toxic compounds produced from
Effects of alternative nicotine delivery systems on cigarette consumption and...Clive Bates
This document summarizes a presentation on the effects of alternative nicotine delivery systems like e-cigarettes on cigarette consumption and smoking prevalence. It discusses data showing declines in smoking rates in countries where vaping products are widely available and accepted like the US, UK, and Sweden. Studies suggest vaping helps increase smoking cessation rates at a population level. The rise of Juul products in the US may have accelerated declines in youth smoking rates there in recent years. Countries in Asia have also seen significant drops in cigarette sales as heat-not-burn tobacco and vaping products gain popularity. However, public health attitudes can influence how quickly reduced risk alternatives are adopted.
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022Clive Bates
Tobacco harm reduction: the biggest public health win of the 21st Century?
1. Tobacco harm reduction
2. Risk communication
3. Policymaking
4. Cause of opposition
5. Innovation
The end of what? UK E-cigarette Summit 2023Clive Bates
The extended version of my presentation to the UK E-cigarette summit 16 November 2023. We look at the following:
1. End of harm or end of nicotine
2. The demand for nicotine
3. The future market for nicotine
4. False risk perceptions
5. Who is to blame
This document provides information on vaping and tobacco harm reduction. It discusses how smoking kills over 96,000 people annually in the UK and notes that median smokers lose 10 years of life expectancy. It then examines smoking prevalence data in different areas and populations in the UK. The document discusses evidence that vaping is substantially less harmful than smoking and may help smokers quit. It notes concerns that restrictive policies could perpetuate smoking. The summary concludes by outlining a framework for risk-proportionate regulation of tobacco and nicotine products.
Tobacco Harm Reduction - an introductionClive Bates
This document provides an introduction to tobacco harm reduction and alternative nicotine products such as e-cigarettes. It summarizes statements from public health organizations that find e-cigarettes to be much less harmful than combustible cigarettes. Research shows e-cigarettes help smokers quit at the population level and are effective cessation tools. The document argues for risk-proportionate regulation and taxation of nicotine products to incentivize smokers to switch to less harmful options and further reduce smoking rates.
E-cigarette Summit US presentation 2018Clive Bates
My presentation at the E-cigarette Summit Washington DC, 30 April 2018. "The urge to ban: 10 questions to ask first" calling for calm over flavors and the latest moral panic over JUUL.
This document outlines six insights on harm reduction:
1. Policies should focus on actual harm rather than products themselves. Harm from smoking, alcohol, drugs, gambling, etc. should be the focus.
2. Policies themselves can cause unintended harm, such as bans on e-cigarettes increasing smoking rates in some cases. The potential harms of policies must be considered.
3. Context is important when considering harm reduction policies. What works in one situation may not be effective in another due to differing contexts.
4. Policies should consider who is actually at risk rather than entire populations. For issues like obesity and salt, not all groups face the same degree of risk.
5. Appro
Is nicotine reduction a viable policy for tobacco control? No, Definitely not...Clive Bates
My critique of the proposal that regulators should reduce the concentration of nicotine in cigarettes to a sub-addictive level - effectively a prohibition of cigarettes as we know them.
Presentation at SRNT 2017 in Florence, Italy on 8 March 2017.
The MRTP process - Seven provocations - FDLI webinar 30 July 2020Clive Bates
My presentation for a Food and Drug Law Institute webinar on the FDA's Modified Risk Tobacco Product process for making risk-related claims about tobacco and nicotine products
NYU College of Global Health - E-cigarette seminar - New YorkClive Bates
E-Cigarettes: The Tectonic Shift in Nicotine and Tobacco Consumption: Opportunity or Threat to Saving Lives?
Clive Bates
Friday, October 19, 2018
NYU School of Law, Greenberg Lounge
40 Washington Square South, New York, New York
Tobacco harm reduction - meetings with Hill staff Clive Bates
This document discusses efforts to reduce smoking and associated harms. It notes that while 36.5 million Americans smoke, consuming 264 billion cigarettes in 2015, smoking causes over 480,000 deaths per year at a cost of over $300 billion. New reduced-risk nicotine products like e-cigarettes and heated tobacco have potential to significantly reduce smoking's toll if made accessible through sensible regulation rather than restrictive policies that protect the cigarette trade. The Royal College of Physicians reviewed evidence that e-cigarettes are much less harmful than smoking and effective for smoking cessation. Most youth e-cigarette use involves just flavors without nicotine. Banning flavors could undermine harm reduction efforts. The proposed Cole-Bishop bill offers a responsible
E-cigarette Summit - The New Tobacco Wars - 7 December 2021Clive Bates
The presentation gives my take on the conflict raging in tobacco control. It looks at where things are going wrong in science, risk communication, policy, and youth politics. It then looks at causes: institutional and cultural inertia. And finally, finds hope in the basic processes of innovation.
Respect Vapers Ireland - webinar on tobacco harm reductionClive Bates
This document summarizes six key things to know about tobacco harm reduction:
1. Smoking prevalence remains high despite efforts. New reduced risk nicotine products like e-cigarettes can help obsolete cigarettes.
2. Expert reviews find e-cigarettes are much less harmful than smoking and can help smokers quit. However, risk perceptions are often exaggerated.
3. The public health benefit comes from addicted smokers switching to less harmful options, not from promoting e-cigarette use alone.
4. Policies should balance appropriate youth protections with supporting harm reduction for adults. Overly restrictive policies can backfire by perpetuating smoking.
1. The document discusses the potential for e-cigarettes and other reduced risk nicotine products to significantly reduce smoking-related harm and death on a global scale. It outlines scenarios where low-risk nicotine products could drive down the number of smokers from over 1 billion currently to just 5% of the global adult population by 2050.
2. However, it notes that an over-regulated environment that reduces product appeal and diversity could limit the public health benefits by decreasing the number of smokers who switch to less harmful alternatives. The document argues for a balanced, evidence-based approach that recognizes both the massive potential gains and relatively minor risks of low-risk nicotine products.
3. In conclusion, it advocates that
Competent or careless? Directions in European policy on low-risk nicotine pr...Clive Bates
Presentation to ENDS conference, 20 April 2021.
Discussion of (1) the threat posed by upcoming EU regulatory developments on tobacco/nicotine; (2) the importance of understanding the underlying public health model; (3) the danger of perverse unintended consequences; (4) the adolescent vaping narrative and what is wrong with it; (5) the proactive alternative - risk-proportionate regulation.
Nicotina - Reducción de riesgos y daños / Nicotine - Risk and Harm ReductionClive Bates
Presentación en línea para el seminario de políticas en Colombia enfocado en políticas de vapeo y consecuencias no deseadas /
Presentation online for policy seminar in Colombia focussed on vaping policy and unintended consequences
Tobacco harm reduction in the UK: e-cigarettes (EC) are making a differenceClive Bates
The document discusses the success of e-cigarettes in helping smokers quit in Leicester City, UK. It notes that success rates were up to 20% higher using e-cigarettes compared to nicotine replacement therapy alone. A stop smoking service in Leicester City began offering free e-cigarette starter kits in 2014 and has seen consistently high quit rates each year since. Common myths about potential health harms, nicotine addiction, e-cigarettes not reflecting smoker preferences, gateway effects, and lack of evidence are addressed. Key organizations in the UK support e-cigarettes as much safer than smoking and effective for harm reduction.
Seven insights into tobacco harm reductionClive Bates
1st Tobacco Harm Reduction Malaysia Scientific Meeting
21 November 2021.
1. The problem is smoking
2. Smoke-free alternatives
3. Quitting smoking with smoke-free alternatives
4. Health concerns
5. Youth vaping
6. Policy and unintended consequences
7. Innovation (and its enemies)
This document discusses various issues related to the regulation of e-cigarettes and vaping. It notes that over-regulation can diminish returns and impose unnecessary costs and restrictions. Too much regulation could compromise product design and appeal, and allow larger tobacco companies to dominate at the expense of smaller manufacturers. There is concern that changing public perceptions of e-cigarettes, driven by misinformation about potential health risks that are not supported by science, could undermine their ability to help smokers quit and reduce harm. The document advocates an evidence-based approach to regulation and public messaging, highlighting that e-cigarettes are much less harmful than smoking and show promise as a smoking cessation tool.
FDLI - Lesson for the US from other jurisdictions - the United Kingdom -29 Oc...Clive Bates
Presentation on the most significant differences between US and UK/EU regulation of tobacco and vaping products. FDLI Tobacco and Nicotine Products Regulation and Policy Conference
This document discusses efforts to develop safer cigarettes through modifying tobacco and reducing tar and toxic compounds. In the 20th century, tobacco companies experimented with adding filters and other additives to cigarettes in attempts to make them less hazardous. One promising attempt involved adding palladium to tobacco, but this "Epic" brand was withheld from the market due to pressure from tobacco control groups and other companies. Later attempts in the 1970s by government and industry to develop "tobacco substitutes" and ultra-low tar cigarettes also failed commercially. Opponents argued safer cigarettes could deter quitting and mask the true risks of smoking. Overall, fully neutralizing the harms of smoking has proved very difficult due to the many toxic compounds produced from
Effects of alternative nicotine delivery systems on cigarette consumption and...Clive Bates
This document summarizes a presentation on the effects of alternative nicotine delivery systems like e-cigarettes on cigarette consumption and smoking prevalence. It discusses data showing declines in smoking rates in countries where vaping products are widely available and accepted like the US, UK, and Sweden. Studies suggest vaping helps increase smoking cessation rates at a population level. The rise of Juul products in the US may have accelerated declines in youth smoking rates there in recent years. Countries in Asia have also seen significant drops in cigarette sales as heat-not-burn tobacco and vaping products gain popularity. However, public health attitudes can influence how quickly reduced risk alternatives are adopted.
India - Economic Times - Consumer Freedom Conclave - 24 Feb 2022Clive Bates
Tobacco harm reduction: the biggest public health win of the 21st Century?
1. Tobacco harm reduction
2. Risk communication
3. Policymaking
4. Cause of opposition
5. Innovation
The end of what? UK E-cigarette Summit 2023Clive Bates
The extended version of my presentation to the UK E-cigarette summit 16 November 2023. We look at the following:
1. End of harm or end of nicotine
2. The demand for nicotine
3. The future market for nicotine
4. False risk perceptions
5. Who is to blame
This document provides information on vaping and tobacco harm reduction. It discusses how smoking kills over 96,000 people annually in the UK and notes that median smokers lose 10 years of life expectancy. It then examines smoking prevalence data in different areas and populations in the UK. The document discusses evidence that vaping is substantially less harmful than smoking and may help smokers quit. It notes concerns that restrictive policies could perpetuate smoking. The summary concludes by outlining a framework for risk-proportionate regulation of tobacco and nicotine products.
African Harm Reduction Exchange - Dec 2022Clive Bates
The science behind Tobacco Harm Reduction …and how it impacts policy development and regulation
1. Smoking is the main problem
2. Smokefree products and science
3. Policy and unintended consequences
4. Innovation (and its enemies)
Rethinking nicotine: illusions, delusions and some conclusionsClive Bates
presentation to the UK E-cigarette Summit on 9 December 2022. Looks at how our approach to nicotine must evolve from a "tobacco harm reduction" to treating nicotine like a socially acceptable recreational stimulant with minimal harm.
10 provocations on why FDA's regulation of tobacco and nicotine is failing the American public. My presentation to the US E-cigarette Summit 2022 in Washington DC, with bonus content of additional background slides added in.
This document provides an overview of electronic cigarettes (e-cigarettes) and discusses associated health risks and environmental impacts. It summarizes that while e-cigarettes were introduced as a safer alternative to regular cigarettes, research shows they may pose similar or additional health hazards. Exposure to e-cigarette vapor can damage lung tissue and impair the immune system. The liquid and vapor contain toxic chemicals like nicotine, formaldehyde, and heavy metals. Regulations are needed to restrict e-cigarette advertising and sales to youth and prevent disposal hazards from batteries and liquid waste. More research is still required to understand long-term health effects.
Review Paper - Addiction of Cigarette Smoking.pdfRAlphabet18
This review paper investigates cigarette smoking addiction, covering its physical and mental mechanisms, societal influences on smoking habits, health risks, quitting difficulties, and cessation interventions.
These are the slides for my talk delivered at the Lisbon Addictions conference October 2019 as part of the FuturiZe round table on safer drugs.
A recording of the presentation can be found on my YouTube channel 'Lynne Talks Vape': https://youtu.be/8jTQvoWu1Pk
Albania National Association of Public health - Harm Reduction ConferenceClive Bates
Seven insights into tobacco harm reduction (20 min version) 20th December 2021.
1.The problem is smoking
2. Smoke-free alternatives
3. Quitting smoking with smoke-free alternatives
4. Health concerns
5. Youth vaping
6. Policy and unintended consequences
7. Innovation (and its enemies)
Nicotine is highly addictive and tobacco use causes more death and disease than any other medical condition. Smoking causes cancer, heart disease, stroke, lung disease and other harmful health effects. Despite public awareness of the health risks, tobacco use remains widespread due to the addictive properties of nicotine and the reinforcement of smoking behavior. Smoking cessation and avoidance of secondhand smoke are critical to reducing the enormous health burden of tobacco use.
This document discusses tobacco control and prevention policies recommended by the American College of Physicians. It provides background on the health and economic impacts of tobacco use. Key points include:
- Tobacco use is the leading preventable cause of death in the US. Comprehensive tobacco control programs are needed to reduce smoking rates.
- The FDA was given authority in 2009 to regulate tobacco, but regulation alone is not enough. States must fund tobacco control efforts and increase tobacco taxes.
- Smokeless tobacco and cigars also harm health. Secondhand smoke exposure causes illness and death in nonsmokers.
This document discusses tobacco harm reduction strategies for engaging healthcare professionals in Nigeria. It defines harm reduction as improving lives without focusing solely on abstinence. Tobacco harm reduction aims to provide safer nicotine delivery alternatives to cigarettes like e-cigarettes and smokeless tobacco. Healthcare professionals can advocate for harm reduction, educate about reduced risk products, and support spiritual and physical wellbeing to help people quit smoking. Embracing harm reduction strategies is key to achieving global smoke-free goals.
This study compared the effects of cigarette smoke, e-cigarette vapor, and pure nicotine on cell viability using HeLa cells. Various concentrations of smoke and vapor condensates collected from a mechanical smoking system were applied to cells for 24 hours. An MTT assay then measured cell viability. Cigarette smoke exposure resulted in lower viability than e-cigarette vapor, but higher than pure nicotine. The results provide insight into the acute toxicity of these substances and whether e-cigarettes may be less harmful than cigarettes.
Presentation to Parlimentary Cross Party Group Drugs and AlcoholStephen Malloy
The document discusses recent trends in drug-related deaths in Scotland and Europe. It notes that drug deaths in Scotland have increased 131% since 1998 and were higher than other parts of the UK and Europe. The majority of deaths occurred in people aged 25-34 who had a history of drug use and overdose. The document also outlines efforts to reduce overdose deaths through prevention programs, training on overdose intervention, and expanded access to naloxone.
William Allan Kritsonis, Editor-in-Chief, NATIONAL FORUM JOURNALS (Founded 1982). Dr. LaVelle Henricks, Texas A&M University-Commerce and colleagues published in national refereed journal.
Dr. William Allan Kritsonis, Distinguished Alumnus, Central Washington University, College of Education and Professional Studies, Ellensburg, Washington; Invited Guest Lecturer, Oxford Round Table, University of Oxford, United Kingdom; Hall of Honor, Prairie View A&M University/Member of the Texas A&M University System.
Running Head LITERATURE REVIEW2LITERATURE REVIEW 2.docxwlynn1
This document discusses the effects of tobacco use. It notes that tobacco consumption peaks between ages 20-40 for both males and females, though males consume more. Smoking rates are higher for some minority groups than the national average. Tobacco use leads to diseases like cancer, heart disease, and addiction. While educating people on the harms of tobacco and making it less affordable can reduce use, tobacco has caused many deaths regardless of socioeconomic background. Lung cancer is a major cause of cancer deaths and is linked to tobacco consumption. Tobacco use also increases risks of other cancers and can damage blood vessels.
Similar to Science based policy or policy based science? (19)
FDLI Annual 2024: seven reasons why the litigation will never stopClive Bates
I give seven reaons underpinning the conflicts between FDA and vape companies...
1. Evidential burdens
2. Opaque success criteria
3. Defining APPH
4. Naivety about youth
5. De facto standard setting
6. Assessing products in isolation
7. Poor market surveillance
US E-cigarette Summit: Taming the nicotine industrial complexClive Bates
I look back to 1997 and simpler time in tobacco control, then look at changes in trade, communications, technology and conclude the market is becoming ungovernable
The APPH Standard: What Does it Actually Mean?Clive Bates
My presentation at the Food & Drug Law Institute Tobacco and Nicotine conference 26 October 2023. I discuss five problems with the APPH concept:
1. No means of trading off different types of benefits and detriments
2. Ignores vaping benefits to youth
3. Blind to harmful unintended consequences of marketing denial orders
4. Impossible to estimate population effects at the product level - the standard only makes sense at the category level.
5. The aggregate effect of thousands of single product PMTA determinations may create adverse effects not captured in any individual application (de fact flavour ban)
I finish with three broad proposals:
1. Assess individual risk and marketing strategy pre-market
2. Assess population effects when it is actually possible to observe them - post-market
3. Conduct a single comprehensive market assessment covering all products, including illicit trade
Barriers and unintended consequences How poor regulation of low-risk alternat...Clive Bates
A shirt presentation to Georgian health experts on the dangers of excessive regulation of safer alternatives to smoking causing perverse unintended consequences.
Regulation of Tobacco Harm Reduction - GFN 2018 ScholarsClive Bates
Global Forum on Nicotine 2018 Scholars meeting on regulation discusses optimum regulation using 4 Ps of marketing framework to consider risk-proportionate regulation
This document outlines what good regulation of vaping products and e-cigarettes could look like according to the author. The key points are:
1. Set product standards for devices, liquids, and testing to ensure quality and safety while allowing for innovation.
2. Allow owners of various establishments like bars, hotels, and workplaces to make their own vaping policies instead of outright bans.
3. Permit advertising of vaping products to adults but with responsible guidelines, and promote meaningful risk communication to encourage informed choice over scare tactics.
4. Consider risk-based taxation that does not tax vaping products the same as combustible cigarettes or spread the tax rates too widely between products.
5
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
2. Agenda
1. Innovation (and its enemies)
2. Nicotine as a recreational drug
3. The weirdness of harm
4. The “youth vaping epidemic”
5. Why so much opposition?
3. Agenda
1. Innovation (and its enemies)
2. Nicotine as a recreational drug
3. The weirdness of harm
4. The “youth vaping epidemic”
5. Why so much opposition?
4. “People smoke for
the nicotine but
die from the tar”
(1976)
Professor Michael Russell 1932-2009
The central insight in smoking and health
4
Russell MJ. Low-tar medium nicotine cigarettes: a new approach to safer smoking. BMJ 1976;1:1430–3
5. Smokeless tobacco
Tobacco based
Pure nicotine based
Heated
aerosol
Unheated
Vaping products Heated tobacco products
“Heat-not-burn”
Items are not shown to scale
Oral nicotine products
5
6. “A diverse class of alternative nicotine
delivery systems (ANDS) has recently
been developed that do not combust
tobacco and are substantially less
harmful than cigarettes”.
“ANDS have the potential to disrupt
the 120-year dominance of the
cigarette and challenge the field on
how the tobacco pandemic could be
reversed if nicotine is decoupled from
lethal inhaled smoke”.
Disrupt the dominance of the cigarette
6
Abrams DB, Glasser AM, et al. Harm Minimization and Tobacco Control: Reframing Societal Views of
Nicotine Use to Rapidly Save Lives Annu Rev Public Health 2018
8. European Union smoking prevalence 2017 - Sweden
Sweden
8
European Commission: Eurobarometer 458, 2017
9. Smoking Disease
9
Ramström L, Wikmans T. Mortality attributable to tobacco among men in Sweden and
other European countries: an analysis of data in a WHO report. Tob Induc Dis. 2014
11. Public Health England reviews of biomarker data
11
Review of biomarker studies
McNeill A, et al Evidence review of ecigarettes and heated tobacco products 2018. A report
commissioned by Public Health England. London: Public Health England.
12. Public Health England reviews of biomarker data
12
McNeill A, et al Evidence review of ecigarettes and heated tobacco products 2018. A report
commissioned by Public Health England. London: Public Health England.
17. Innovation and its enemies…
“Claims about the promise of new technology are at times greeted with
skepticism, vilification or outright opposition—often dominated by slander,
innuendo, scare tactics, conspiracy theories and misinformation.
“The assumption that new technologies carry unknown risks guides much of
the debate. This is often amplified to levels that overshadow the dangers of
known risks.”
Juma C. Innovation and Its Enemies: Why People Resist New Technologies. Oxford, New York: Oxford University Press; 2016.
18. Agenda
1. Innovation (and its enemies)
2. Nicotine as a recreational drug
3. The weirdness of harm
4. The “youth vaping epidemic”
5. Why so much opposition?
19. Three perspectives
1. Predatory: the nicotine maintenance strategy of Big Tobacco
– Fundamental and irreconcilable conflict between the interests of the
tobacco industry and public health
FCTC Article 5.3 Guidelines
2. Harm reduction: save millions of lives by reducing smoking
– Appropriate for the protection of public health
FDA
3. The pleasure principle: leave us alone, we just like nicotine
– Candy doesn’t have to have a point. That’s why it’s candy.
Charlie and the Chocolate Factory
20. Last 10 years – about a one-third cut in smoking
0
5
10
15
20
25
30
%
cigarette
smokers
(3
month
moving
average)
Smoking prevalence trend - last ten years - England
~One-third cut
20
University College London, Smoking in England, Smoking Toolkit Survey, 2020
21. Smoking and vaping 2019 – Great Britain (ONS)
ONS, E-cigarette use in Great Britain in 2019, July 2020
~3m vapers
~8m smokers
21
22. Smoking and vaping – “making smoking products obsolete”
5% prevalence
Two-thirds cut
22
ONS, E-cigarette use in Great Britain in 2019, July 2020
23. 5. The irreconcilable conflict principle: cannibalising cigarette sales
Total - steady decline
Cigs – rapid decline
Heated Tobacco – sharp rise
Phillip Morris International Data
24. Extremely rapid decline in smoking
0
5
10
15
20
25
30
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Norway: daily tobacco use
women age 16-24 - per cent
17 percent
1 percent
25. Gentle decline in overall nicotine use
0
5
10
15
20
25
30
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Norway: daily tobacco use
women age 16-24 - per cent
29. Agenda
1. Innovation (and its enemies)
2. Nicotine as a recreational drug
3. The weirdness of harm
4. The “youth vaping epidemic”
5. Why so much opposition?
32. Bad news sells newspapers
32
Vlachopoulos C et al (2016) Electronic
Cigarette Smoking Increases Aortic
Stiffness and Blood Pressure in Young
Smokers. J Am Coll Cardiol 67:2802–2803.
Origin
Vlachopoulos C et al (2003) Effect of
caffeine on aortic elastic properties and
wave reflection. J Hypertens 21:563–70.
Context
See: Clive Bates, When you thought public health could go no lower - it just did, Counterfactual, 2016
33. Weirdness of harm: why people quit
Gallus S, Muttarak R, Franchi M, et al. Why do smokers quit? Eur J Cancer Prev 2013;22(1):96–101.
34. Weirdness of harm: driver of abstinence
Gallus S, Muttarak R, Franchi M, et al. Why do smokers quit? Eur J Cancer Prev 2013;22(1):96–101.
35. Addiction
Addiction is marked by a change in behavior caused
by the biochemical changes in the brain after
continued substance abuse. Substance use becomes
the main priority of the addict, regardless of the harm
they may cause to themselves or others.
Addiction Center
A compulsive, chronic, physiological or
psychological need for a habit-forming substance,
behavior, or activity having harmful physical,
psychological, or social effects
Meriam Webster Dictionary
Addiction is a complex condition, a brain disease
that is manifested by compulsive substance use
despite harmful consequence. People with
addiction (severe substance use disorder) have an
intense focus on using a certain substance(s),
such as alcohol or drugs, to the point that it takes
over their life.
American Psychiatric Association
Addiction is defined as a chronic, relapsing
disorder characterized by compulsive drug
seeking and use despite adverse
consequences.
National Institute on Drug Abuse (NIDA)
36. Addiction and harm
Addiction is marked by a change in behavior caused
by the biochemical changes in the brain after
continued substance abuse. Substance use becomes
the main priority of the addict, regardless of the harm
they may cause to themselves or others.
Addiction Center
A compulsive, chronic, physiological or
psychological need for a habit-forming substance,
behavior, or activity having harmful physical,
psychological, or social effects
Meriam Webster Dictionary
Addiction is a complex condition, a brain disease
that is manifested by compulsive substance use
despite harmful consequence. People with
addiction (severe substance use disorder) have an
intense focus on using a certain substance(s),
such as alcohol or drugs, to the point that it takes
over their life.
American Psychiatric Association
Addiction is defined as a chronic, relapsing
disorder characterized by compulsive drug
seeking and use despite adverse
consequences.
National Institute on Drug Abuse (NIDA)
37. Agenda
1. Innovation (and its enemies)
2. Nicotine as a recreational drug
3. The weirdness of harm
4. The “youth vaping epidemic”
5. Why so much opposition?
41. Drill down into the 2019 NYTS headline
27.5%
Percentage of high school students who used e-cigarettes in past 30 days
HEADLINE
more than one
in five high
school
students is
vaping
41
42. We can distinguish between frequent and infrequent use
Frequent use
≥20 days per
month
Infrequent use
≤ 19 days per
month
9.4%
18.1%
Most teen
vapers (66%)
are not
frequent users
42
Derived from: Jarvis M et al. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey
2017-2019 reveal about high school e-cigarette use in the USA? Qeios 2020 [Personal communication Martin Jarvis]
43. We can distinguish between prior tobacco users and never-users
8.8% 18.7%
Most teen
vapers (68%)
are prior
tobacco users
Prior tobacco use
Never used tobacco
43
Derived from: Jarvis M et al. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey
2017-2019 reveal about high school e-cigarette use in the USA? Qeios 2020 [Personal communication Martin Jarvis]
44. We can segment by both frequency and prior tobacco use
Prior tobacco use
Never used tobacco
Frequent use
≥20 days per
month
Infrequent use
≤ 19 days per
month
1.4% 8.0%
10.7%
7.4%
44
Derived from: Jarvis M et al. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey
2017-2019 reveal about high school e-cigarette use in the USA? Qeios 2020 [Personal communication Martin Jarvis]
45. We can segment by both frequency and prior tobacco use
Prior tobacco use
Never used tobacco
Frequent use
≥20 days per
month
Infrequent use
≤ 19 days per
month
1.4% 8.0%
10.7%
7.4%
Few teen
vapers (5%) are
both tobacco
naïve and
frequent users
45
Derived from: Jarvis M et al. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey
2017-2019 reveal about high school e-cigarette use in the USA? Qeios 2020 [Personal communication Martin Jarvis]
46. We can identify a significant group who may benefit
Frequent use
≥20 days per
month
Infrequent use
≤ 19 days per
month
1.4% 8.0%
10.7%
7.4%
Most of the
teen frequent
vapers (85%)
are prior
tobacco users
– vaping may
be helping
them
Prior tobacco use
Never used tobacco
46
Derived from: Jarvis M et al. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey
2017-2019 reveal about high school e-cigarette use in the USA? Qeios 2020 [Personal communication Martin Jarvis]
49. Agenda
1. Innovation (and its enemies)
2. Nicotine as a recreational drug
3. The weirdness of harm
4. The “youth vaping epidemic”
5. Why so much opposition?
52. Royal College of Physicians – unintended consequences
52
Royal College of Physicians. Nicotine without smoke: tobacco harm reduction London: RCP; 2016.
53. …if a risk-averse, precautionary approach
makes e-cigarettes:
• less easily accessible
• less palatable or acceptable
• more expensive
• less consumer friendly
• pharmacologically less effective
• inhibits innovation …
…then it causes harm by perpetuating
smoking.
Royal College of Physicians – unintended consequences
53
Royal College of Physicians. Nicotine without smoke: tobacco harm reduction London: RCP; 2016.
54. Agenda
1. Innovation (and its enemies)
2. Nicotine as a recreational drug
3. The weirdness of harm
4. The “youth vaping epidemic”
5. Why so much opposition?
Thankyou!
Counterfactual
clivedbates@gmail.com
www.clivebates.com
@clive_bates
Editor's Notes
Vaping products
Top row shows:
1st generation cig-a-likes
2nd generation ego or ‘pen’ type devices
3rd generation tanks / mods type
Bottom row shows
Large electronic hookah
Small shisha pipes
Electronic pipe
… there are many other configurations
Heated tobacco products – sometimes referred to as heat-not-burn to distinguish between combustible products
Shows the iQOs, Ploom and Glo products
Novel nicotine products - shows
Nicoccino – a nicotine containing film
Zonnic – a range of nicotine products – lozenges, gum etc
Voke – a cold aerosol (approved but not marketed)
Niorette – cross-over NRT
Smokeless tobacco
Snus
Moist snuff
Tobacco-based lozenge